Antibodies are Y-shaped proteins (immunoglobulins) composed of two heavy chains and two light chains, designed to bind specific epitopes on antigens . Their variable regions (VH/VL domains) determine specificity, while constant regions (CH/CL domains) mediate immune effector functions . For example, monoclonal antibodies like MK-5890 (anti-CD27) and prasinezumab (anti-α-synuclein) demonstrate tailored epitope recognition and therapeutic applications .
Several antibodies in the search results target specific disease-associated proteins:
CD27 agonist MK-5890: Enhances T-cell activity in cancer immunotherapy, with sub-nanomolar binding affinity and epitope mapping via X-ray crystallography .
P2X7 receptor antibody (L4 clone): Used in flow cytometry assays to study receptor expression and function .
RSV p27 antibodies: Recognize a cleavage peptide (aa 101–121) of the viral fusion protein, with age-dependent immunodominance in pediatric populations .
If "ppk27 Antibody" refers to a novel therapeutic or diagnostic antibody:
Target identification: It would likely bind a specific protein (e.g., ppk27, a hypothetical variant of ppk301, an ion channel in mosquitoes ).
Therapeutic relevance: Could address conditions linked to ppk27 expression, analogous to how anti-α-synuclein antibodies target neurodegenerative diseases .
Development challenges: Requires epitope mapping, functional assays (e.g., binding affinity via ELISA), and preclinical validation .
Given the absence of "ppk27 Antibody" in the search results, future studies could:
Characterize ppk27 protein: Determine its role in cellular processes (e.g., ion transport, signaling).
Develop epitope-specific antibodies: Use phage display or hybridoma techniques to generate high-affinity reagents .
Validate therapeutic potential: Assess efficacy in disease models (e.g., oncology, neurodegeneration) using flow cytometry and in vivo assays .
KEGG: spo:SPBC337.04
STRING: 4896.SPBC337.04.1
Ppk27 (serine/threonine-protein kinase ppk27, EC 2.7.11.1) is a protein kinase found in the fission yeast Schizosaccharomyces pombe. It's encoded by the gene SPBC337.04 and is significant in cell signaling pathways . As a serine/threonine kinase, ppk27 plays a potential role in phosphorylation events that regulate various cellular processes. Research on ppk27 contributes to our understanding of kinase-dependent signaling networks in eukaryotic cells, particularly in the context of cell cycle regulation, stress responses, and potentially genome stability in S. pombe .
Multiple methodologies can be employed for detecting ppk27 in fission yeast:
Western blotting: The most common approach uses anti-ppk27 antibodies for detection after protein separation by SDS-PAGE. This requires proper sample preparation from S. pombe cells, protein transfer to membranes, and optimization of antibody dilutions .
Immunoprecipitation: Anti-ppk27 antibodies can be used in pull-down experiments to isolate ppk27 and its binding partners from yeast cell lysates .
Mass spectrometry: For identification and quantification of ppk27 and its post-translational modifications, particularly phosphorylation events .
Quantitative PCR: For analyzing ppk27 gene expression levels at the transcript level, though this doesn't detect the protein itself .
For optimal results, researchers should use polyclonal antibodies with verified specificity against S. pombe ppk27, such as rabbit-derived antibodies that recognize multiple epitopes .
Efficient sample preparation is crucial for ppk27 detection. The following protocol is recommended based on established methods:
Sample preparation protocol:
Culture S. pombe cells to mid-log phase (OD600 ≈ 0.5-0.8)
Harvest cells by centrifugation (3,000 x g for 5 minutes)
Wash cell pellet with cold PBS
Resuspend in lysis buffer containing:
50 mM Tris-HCl (pH 7.5)
150 mM NaCl
1% Triton X-100
1 mM EDTA
Protease inhibitor cocktail
Phosphatase inhibitors (critical for preserving phosphorylation status)
Disrupt cells using glass beads in a cell disruptor (8 cycles of 30 seconds)
Clarify lysate by centrifugation (14,000 x g for 15 minutes at 4°C)
Quantify protein concentration using Bradford or BCA assay
For Western blot detection, 20-50 μg of total protein is typically sufficient, while immunoprecipitation experiments may require 200-500 μg of protein .
Verifying antibody specificity for ppk27 presents several challenges:
Key challenges:
Cross-reactivity with other kinases with similar epitopes
Variable expression levels of ppk27 across growth conditions
Potential post-translational modifications affecting antibody recognition
Limited commercial availability of validated anti-ppk27 antibodies for S. pombe
Recommended verification approaches:
Genetic controls: Use ppk27 deletion strains (Δppk27) as negative controls to confirm antibody specificity .
Epitope-tagged validation: Compare detection between native ppk27 and epitope-tagged versions (e.g., HA, FLAG, or myc-tagged ppk27) .
Peptide competition assay: Pre-incubate antibody with purified ppk27 peptide before Western blotting to confirm signal specificity.
Multiple antibody validation: Use antibodies targeting different epitopes of ppk27 to confirm detection.
Mass spectrometry confirmation: Verify immunoprecipitated proteins by mass spectrometry to confirm ppk27 identity .
For example, in Wang's study, epitope tagging of proteins was performed by PCR-based genomic integration followed by verification using antibodies against both the tag and the native protein to ensure specificity of detection .
Optimizing pull-down experiments for ppk27 requires careful consideration of several parameters:
Optimization protocol:
Cell lysis optimization:
Use cryogenic disruption for efficient lysis of S. pombe cells
Employ gentle detergents (0.1-0.5% NP-40 or Triton X-100) to preserve protein complexes
Include phosphatase inhibitors to maintain phosphorylation-dependent interactions
Antibody selection and immobilization:
Use affinity-purified antibodies against ppk27
Alternatively, use antibodies against epitope tags if working with tagged ppk27
Pre-clear lysates with protein A/G beads to reduce non-specific binding
Cross-link antibodies to beads using dimethyl pimelimidate to prevent antibody leaching
Binding conditions:
Optimize salt concentration (typically 100-150 mM NaCl)
Adjust incubation time (2-4 hours at 4°C or overnight)
Include BSA (0.1-0.5%) to reduce non-specific binding
Washing stringency:
Perform 3-5 washes with increasing stringency
Analyze both bound fractions and washes to monitor loss of specific interactions
Elution strategies:
Competitive elution with ppk27 peptide
Low pH elution (glycine buffer, pH 2.5-3.0)
SDS elution for maximum recovery
Controls:
This optimized protocol significantly improves the signal-to-noise ratio in ppk27 interaction studies, as demonstrated in co-immunoprecipitation experiments in S. pombe .
Identifying ppk27 phosphorylation targets requires a multi-faceted approach:
Recommended methodologies:
In vitro kinase assays:
Purify recombinant ppk27 (wild-type and kinase-dead mutants)
Incubate with candidate substrates or cell lysate fractions
Detect phosphorylation using [γ-32P]ATP or phospho-specific antibodies
Analyze by autoradiography or Western blotting
Substrate trapping:
Generate catalytically inactive ppk27 mutants that bind but don't phosphorylate substrates
Perform pull-down experiments followed by mass spectrometry
Compare bound proteins between wild-type and substrate-trapping mutants
Phosphoproteomics:
Compare phosphoproteomes of wild-type and Δppk27 strains
Enrich phosphopeptides using TiO2 or immobilized metal affinity chromatography
Analyze by LC-MS/MS to identify differentially phosphorylated proteins
Look for phosphorylation at S/T residues in consensus motifs
Genetic interaction mapping:
Perform synthetic genetic array analysis with ppk27 deletion strains
Identify genes showing genetic interactions, which may include substrates
Bioinformatic prediction and validation:
Use algorithms to predict ppk27 phosphorylation sites based on consensus sequences
Validate predictions experimentally using site-directed mutagenesis of candidate substrates
This integrated approach has been successful in identifying substrates of other kinases in S. pombe and could be applied to ppk27 .
Designing experiments to elucidate ppk27's role in stress responses requires systematic approaches:
Experimental design framework:
Gene expression analysis:
Monitor ppk27 expression levels under various stress conditions (oxidative, heat, osmotic, nutrient deprivation)
Use RT-qPCR or RNA-seq to quantify transcriptional changes
Compare with known stress-responsive kinases as positive controls
Phenotypic characterization:
Generate ppk27 deletion (Δppk27) and overexpression strains
Assess growth rates under normal and stress conditions
Perform spot assays with serial dilutions on media containing stressors
Measure survival rates after acute stress exposure
Phosphorylation dynamics:
Use phospho-specific antibodies to monitor ppk27 activation under stress
Perform time-course experiments to track phosphorylation changes
Identify upstream kinases using candidate approach or kinase inhibitors
Subcellular localization:
Create GFP-tagged ppk27 to track localization changes during stress
Use immunofluorescence with anti-ppk27 antibodies as an alternative approach
Perform co-localization studies with organelle markers
Genetic interaction analysis:
Cross Δppk27 with deletion strains of known stress response genes
Analyze epistatic relationships to position ppk27 in signaling pathways
Perform genome-wide synthetic genetic array analysis
Transcriptional targets:
Perform RNA-seq comparing wild-type and Δppk27 strains under stress
Identify differentially expressed genes regulated by ppk27
This comprehensive approach allows for detailed characterization of ppk27's role in stress response pathways .
To investigate ppk27's potential role in cell cycle regulation, researchers should employ the following methodologies:
Experimental approaches:
Cell synchronization and kinetics analysis:
Synchronize cells using cdc25-22 temperature-sensitive mutants or centrifugal elutriation
Collect time-course samples across the cell cycle
Analyze ppk27 protein levels and phosphorylation status by Western blotting
Monitor cell cycle markers (e.g., Cdc13, Cut2) in parallel
Cell cycle-specific phenotypic analysis:
Characterize Δppk27 mutant cell morphology using microscopy
Measure DNA content using flow cytometry to identify cell cycle arrest points
Calculate doubling time and cell size at division
Assay for mitotic defects using DAPI staining and anti-tubulin antibodies
Genetic interaction studies:
Create double mutants with known cell cycle regulators
Test synthetic lethality or rescue with cdc mutants
Position ppk27 in the cell cycle control network
Cell cycle-dependent activity assays:
Immunoprecipitate ppk27 from synchronized cells
Perform in vitro kinase assays to measure activity changes across the cell cycle
Identify cell cycle-specific substrates
Substrate identification:
Use BioID or proximity labeling techniques to identify interactors in different cell cycle phases
Perform phosphoproteomics of synchronized Δppk27 vs. wild-type cells
Validate candidates with site-specific phospho-mutants
Chemical genetic approaches:
Generate analog-sensitive ppk27 mutants (ppk27-as)
Use specific inhibitors to acutely inhibit ppk27 at different cell cycle stages
Monitor immediate consequences on cell cycle progression
This multi-faceted approach provides comprehensive insights into ppk27's role in cell cycle control .
When confronted with conflicting results in ppk27 antibody experiments, researchers should follow this systematic troubleshooting framework:
Troubleshooting protocol:
Antibody validation reassessment:
Verify antibody specificity using Δppk27 control strains
Test multiple antibody batches or sources
Perform epitope mapping to confirm recognition sites
Evaluate cross-reactivity with related kinases
Experimental condition analysis:
Create a comparison table of differing experimental conditions:
| Parameter | Experiment A | Experiment B | Potential Impact |
|---|---|---|---|
| Cell lysis method | Mechanical | Chemical | Protein solubility, complex integrity |
| Buffer composition | Low salt | High salt | Interaction stability, antibody binding |
| Cell growth phase | Log phase | Stationary | Expression levels, phosphorylation status |
| Detection method | Chemiluminescence | Fluorescence | Sensitivity, quantification accuracy |
| Antibody dilution | 1:1000 | 1:5000 | Signal intensity, background |
Post-translational modification considerations:
Test if phosphorylation affects antibody recognition
Use phosphatase treatment of samples to standardize phosphorylation status
Consider other modifications (e.g., ubiquitination) that might mask epitopes
Reproducing conflicting conditions:
Systematically test each variable individually
Document all parameters meticulously
Use positive controls to validate each experimental condition
Alternative method validation:
Confirm key findings with orthogonal techniques (e.g., mass spectrometry)
Use epitope-tagged ppk27 as an alternative detection strategy
Consider in vitro translation of ppk27 as a controlled standard
Biological variability assessment:
Evaluate strain background differences
Consider environmental conditions affecting ppk27 expression
Test different growth media and stress conditions
This systematic approach helps resolve conflicting results and enhances experimental reproducibility .
Investigating ppk27's potential role in genomic stability requires specialized techniques:
Methodological approaches:
DNA damage response assays:
Compare survival of wild-type and Δppk27 strains after exposure to DNA-damaging agents (UV, MMS, hydroxyurea, cisplatin)
Perform epistasis analysis with known DNA damage response genes (rad3, chk1, cds1)
Monitor checkpoint activation by assessing Chk1 phosphorylation in Δppk27 strains
Measure DNA repair efficiency using repair reporter assays
Chromosome stability assessment:
Quantify chromosome loss rates using adenine color sectoring assays
Measure mitotic recombination frequencies
Analyze telomere length by Southern blotting
Perform pulsed-field gel electrophoresis to detect chromosome fragmentation
Replication dynamics:
Monitor DNA replication using BrdU incorporation assays
Analyze replication fork progression by DNA combing
Detect stalled replication forks using γH2A.X staining
Study ppk27 localization during S phase
Genetic interactions with replication and repair machinery:
Create double mutants with key DNA replication factors
Test genetic interactions with components of different repair pathways
Screen for synthetic lethality with replication checkpoint genes
Chromatin structure analysis:
Perform chromatin immunoprecipitation to study ppk27 association with chromatin
Analyze histone modifications in Δppk27 mutants
Assess nucleosome positioning by MNase sensitivity assays
This comprehensive approach enables detailed characterization of ppk27's role in maintaining genomic stability, similar to studies performed with other kinases in S. pombe .
Developing phospho-specific antibodies for ppk27 requires a systematic approach:
Development and validation protocol:
Phosphorylation site identification:
Perform in silico analysis to predict potential phosphorylation sites
Use mass spectrometry to identify actual phosphorylation sites in vivo
Focus on conserved residues with functional significance
Phosphopeptide design:
Synthesize phosphopeptides (10-15 amino acids) containing the phosphorylated residue
Include a terminal cysteine for conjugation to carrier proteins
Consider synthesizing both phosphorylated and non-phosphorylated versions
Immunization strategy:
Conjugate phosphopeptides to KLH or BSA carriers
Immunize rabbits with phosphopeptide conjugates
Boost at appropriate intervals to maximize antibody production
Antibody purification:
Purify serum using protein A/G chromatography
Perform affinity purification using phosphopeptide columns
Remove antibodies recognizing non-phosphorylated epitopes using non-phosphopeptide columns
Validation approaches:
Test specificity using Western blots with phosphatase-treated samples
Validate with phospho-mimetic (S/T to E/D) and phospho-dead (S/T to A) mutants
Confirm recognition of phosphorylated ppk27 from cells under conditions known to induce phosphorylation
Perform peptide competition assays with phospho and non-phospho peptides
Cross-reactivity assessment:
Test against related kinases with similar phosphorylation motifs
Evaluate specificity across different experimental conditions
Perform immunoprecipitation followed by mass spectrometry to confirm specificity
This methodical approach ensures development of highly specific phospho-antibodies for studying ppk27 regulation and function .
The field of ppk27 research faces several challenges that require innovative approaches:
Current limitations and future directions:
Limited functional characterization:
Current limitation: Incomplete understanding of ppk27's physiological substrates and pathways.
Future approach: Implement BioID or proximity labeling techniques to identify interaction partners in their native cellular context.
Technical challenges in protein detection:
Current limitation: Difficulties in developing specific antibodies for native ppk27.
Future approach: Apply CRISPR-Cas9 genome editing to tag endogenous ppk27 at either terminus while maintaining functionality.
Redundancy with other kinases:
Current limitation: Potential functional overlap with related kinases masking phenotypes.
Future approach: Generate multiple kinase deletion strains and apply chemical genetics using analog-sensitive mutants for temporal control.
Substrate identification:
Current limitation: Challenges in distinguishing direct from indirect substrates.
Future approach: Implement phosphoproteomics combined with substrate consensus motif analysis and in vitro validation.
Pathway positioning:
Current limitation: Unclear position of ppk27 in signaling networks.
Future approach: Systematic epistasis analysis with known pathway components and phosphorylation site mapping.
Translational relevance:
Current limitation: Unknown conservation of function in higher eukaryotes.
Future approach: Complementation studies with mammalian orthologs and comparative pathway analysis.
Proposed experimental framework for addressing gaps:
| Research Gap | Short-term Approach | Long-term Strategy |
|---|---|---|
| Substrate identification | Phosphoproteomics comparing WT vs. Δppk27 | Develop consensus motif and substrate prediction algorithms |
| Signaling pathway | Targeted epistasis with known kinases | Genome-wide genetic interaction mapping |
| Regulatory mechanisms | Map phosphorylation sites on ppk27 | Resolve structure of ppk27 with activators/inhibitors |
| Physiological function | Phenotypic analysis under diverse conditions | Develop condition-specific activity sensors |
These approaches will address current limitations and advance our understanding of ppk27's functions in cellular processes .
When working with ppk27 antibodies in Western blotting experiments, optimized stripping and reprobing protocols are essential:
Recommended stripping protocol:
Mild stripping procedure (preferred for ppk27 detection):
Wash the membrane in PBS or TBS for 5 minutes to remove ECL substrate
Incubate membrane in stripping buffer (0.1M glycine, 0.1% SDS, 1% Tween 20, pH 2.2) for 10 minutes at room temperature
Repeat with fresh stripping buffer for another 10 minutes
Wash membrane with PBS or TBS (3 × 5 minutes)
Re-block membrane before next antibody incubation
Harsh stripping procedure (for difficult-to-remove antibodies):
Incubate membrane in harsh stripping buffer (62.5 mM Tris-HCl, 2% SDS, 0.7% β-mercaptoethanol, pH 6.7) at 50°C for 5-10 minutes
Wash extensively with PBS or TBS (6 × 5 minutes)
Re-block membrane thoroughly before next antibody incubation
Commercial stripping buffer option:
Validation of stripping efficiency:
Incubate stripped membrane with ECL substrate and expose to confirm absence of signal
If signal persists, repeat stripping procedure
For multiplex detection, consider fluorescent secondary antibodies instead of stripping
This optimized protocol minimizes epitope damage while ensuring complete removal of previous antibodies, critical for sequential detection of ppk27 and its post-translational modifications or interaction partners .
Robust immunofluorescence studies of ppk27 localization require comprehensive controls:
Essential controls for immunofluorescence:
Genetic controls:
Δppk27 deletion strain as negative control
Overexpression strain as positive control
Epitope-tagged ppk27 strain for antibody validation
Antibody specificity controls:
Primary antibody omission control
Isotype-matched irrelevant antibody control
Peptide competition assay (pre-incubate antibody with immunizing ppk27 peptide)
Multiple antibodies targeting different ppk27 epitopes
Signal verification controls:
Low ppk27-expressing cells vs. high ppk27-expressing cells
Cell cycle-dependent localization controls (if relevant)
Co-localization with known markers of subcellular compartments
Comparison of fixed vs. live cell imaging (for GFP-tagged ppk27)
Technical controls:
Autofluorescence control (no antibody)
Secondary antibody-only control
Fixed but non-permeabilized cells to confirm intracellular staining
Biological validation:
Stimulus-dependent relocalization (if expected)
Mutant forms with altered localization (e.g., NLS or NES mutants)
Co-localization with known interaction partners
Sample preparation controls:
Different fixation methods (paraformaldehyde, methanol)
Various permeabilization reagents (Triton X-100, saponin)
Antigen retrieval assessment
Optimizing co-immunoprecipitation (co-IP) protocols for ppk27 requires addressing several critical parameters:
Optimized co-IP protocol for ppk27:
Cell lysis optimization:
Use gentle lysis buffers to preserve protein-protein interactions:
Base buffer: 50 mM HEPES (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1 mM DTT
Detergent options: 0.5% NP-40 or 0.2% Triton X-100 (test both)
Protease inhibitor cocktail (freshly added)
Phosphatase inhibitors (10 mM NaF, 1 mM Na3VO4, 50 mM β-glycerophosphate)
Optimize cell disruption method (cryogenic grinding for yeast cells)
Clarify lysate at 14,000 × g for 15 minutes at 4°C
Pre-clearing optimization:
Pre-clear lysate with Protein A/G beads (30 μl beads per 1 ml lysate)
Incubate for 1 hour at 4°C with rotation
Remove beads by centrifugation (1,000 × g for 1 minute)
Antibody binding parameters:
Test different antibody amounts (2-5 μg per 500 μg protein lysate)
Optimize incubation time (2 hours vs. overnight at 4°C)
Compare direct antibody addition vs. pre-binding to beads
Test crosslinking antibody to beads to prevent antibody contamination in eluates
Washing optimization:
Test washing buffer stringency:
Low stringency: Lysis buffer
Medium stringency: Lysis buffer with 250 mM NaCl
High stringency: Lysis buffer with 300 mM NaCl or 0.1% SDS
Optimize number of washes (3-5 washes)
Compare quick vs. extended washes (1 minute vs. 5 minutes)
Elution strategy comparison:
Denaturing: 1× SDS sample buffer at 95°C for 5 minutes
Native: Excess competing peptide
Acidic: 0.1 M glycine (pH 2.5) followed by immediate neutralization
Detection optimization:
Test sample loading amounts (25-100% of IP)
Optimize transfer conditions for efficient transfer of interacting proteins
Consider gradient gels for detecting interactions with proteins of various sizes
Controls:
Input control (5% of starting material)
IgG control (same species as ppk27 antibody)
Δppk27 strain control
Reciprocal IP with antibodies against suspected interactors